総合代謝パネル検査市場：疾患別、検査タイプ別、エンドユーザー別-2025-2030年の世界予測

総合代謝パネル検査市場は、2023年に92億8,000万米ドルと評価され、2024年には102億6,000万米ドルに達すると予測され、CAGR 10.65％で成長し、2030年には188億6,000万米ドルになると予測されています。

包括的代謝パネル（CMP）検査市場には、グルコース値、電解質バランス、腎機能、肝臓の状態を測定し、患者の全体的な代謝の健康状態に関する重要なデータを提供する幅広い診断用血液検査が含まれます。生活習慣病や慢性疾患の増加により、CMP検査は日常的な健康診断や病気の進行のモニタリングに広く応用されています。ヘルスケアプロバイダー、検査室、病院が主要なエンドユーザーである一方、予防医療とポイントオブケア検査ソリューションに対する患者の嗜好の高まりが需要を牽引しています。市場の洞察により、自動検査技術の進歩、個別化医療へのシフト、新興国におけるヘルスケアインフラの拡大など、需要急増に大きく寄与する主要な成長要因が明らかになった。診断精度の向上、より良いデータ解釈のための人工知能の統合、家庭用ポータブル検査機器の開発などに潜在的なビジネスチャンスが存在します。しかし、規制上のハードル、高度な診断ツールに関連する高コスト、特定地域における認識不足といった課題が、市場の成長を阻害する可能性があります。価格敏感性や償還の問題は、市場力学をさらに複雑にしています。業界がこうしたハードルを越えることを目指す中、技術革新の機が熟している分野としては、次世代バイオマーカーパネルの開発、より優れた診断予測のための機械学習アルゴリズムの改善、アクセス性と患者関与を高めるための遠隔医療プラットフォームとCMP検査の統合などが挙げられます。コスト削減と認知度向上に向けた努力は、官民のパートナーシップが市場拡大を促進することで、好ましい結果をもたらす可能性があります。CMP検査市場の基本的な性質は強固でありながら進化しており、主に技術統合と健康・福祉意識の重視が原動力となっています。

市場力学：急速に進化する総合代謝パネル検査市場の主要市場インサイトを公開

総合代謝パネル検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の罹患率の増加
  • 国民における早期診断・治療の潜在的ニーズ
  • 高齢者人口の増加と生検プロセスの増加
• 市場抑制要因
  • 検査で誤った結果が出る可能性
• 市場機会
  • 効率改善とエラー削減のための革新的ソリューションのイントロダクションの台頭
  • 検査室の自動化システムとバイオインフォマティクスおよびデータ管理ソリューションの継続的な統合
• 市場の課題
  • 規制制度の変化によるメーカー間の曖昧さ

ポーターの5つの力：総合代謝パネル検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場ポジショニングを確保することができます。

PESTLE分析：総合代謝パネル検査市場における外部からの影響の把握

外部マクロ環境要因は、総合代謝パネル検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析総合代謝パネル検査市場における競合情勢の把握

総合代謝パネル検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス総合代謝パネル検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、総合代謝パネル検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨総合代謝パネル検査市場における成功への道筋を描く

総合代謝パネル検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の発生率増加
    • 人口の早期診断と治療の必要性
    • 高齢者人口の増加と生検の増加
  • 抑制要因
    • テストで誤った結果が出る確率
  • 機会
    • 効率性を向上させ、エラーを削減する革新的なソリューションのイントロダクション
    • バイオインフォマティクスおよびデータ管理ソリューションと研究室の自動化システムの継続的な統合
  • 課題
    • 規制システムの変更によりメーカー間で曖昧さが生まれる
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 総合代謝パネル検査市場：疾患別

• 糖尿病
• 腎臓病
• 肝臓病

第7章 総合代謝パネル検査市場テストタイプ別

• 電解質
• グルコース
• 腎臓検査
• 肝機能検査
• タンパク質

第8章 総合代謝パネル検査市場：エンドユーザー別

• 研究室
• 概念実証

第9章 南北アメリカの総合代謝パネル検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の総合代謝パネル検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの総合代謝パネル検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abaxis by Zoetis Inc.
• Abbott Laboratories
• ARUP Laboratories
• Baptist Health Medical Group
• CENTOGENE N.V.
• Cleveland HeartLab, Inc.
• Laboratory Corporation of America Holdings
• NeoGenomics Laboratories, Inc.
• Private MD Labs
• Quest Diagnostics Incorporated
• Scion Lab Services, LLC
• Siemens Healthcare GmbH
• SYNLAB International GmbH
• Testing.com by OneCare Media
• Walk-In Lab, LLC

LIST OF FIGURES

• FIGURE 1. COMPREHENSIVE METABOLIC PANEL TESTING MARKET RESEARCH PROCESS
• FIGURE 2. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. COMPREHENSIVE METABOLIC PANEL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COMPREHENSIVE METABOLIC PANEL TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY KIDNEY DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LIVER DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY ELECTROLYTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY GLUCOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY KIDNEY TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LIVER FUNCTIONAL TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY LABORATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY POC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CHINA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ITALY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 116. POLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 119. QATAR COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM COMPREHENSIVE METABOLIC PANEL TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. COMPREHENSIVE METABOLIC PANEL TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. COMPREHENSIVE METABOLIC PANEL TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Comprehensive Metabolic Panel Testing Market was valued at USD 9.28 billion in 2023, expected to reach USD 10.26 billion in 2024, and is projected to grow at a CAGR of 10.65%, to USD 18.86 billion by 2030.

The Comprehensive Metabolic Panel (CMP) testing market encompasses a wide range of diagnostic blood tests that measure glucose levels, electrolyte balance, kidney function, and liver status to provide essential data on a patient's overall metabolic health. Necessitated by the growing incidence of lifestyle-related disorders and chronic diseases, CMP testing finds extensive application in both routine health examinations and the monitoring of disease progression. Healthcare providers, laboratories, and hospitals serve as primary end-users, while the increasing patient preference for preventive healthcare and point-of-care testing solutions drives demand. Market insights reveal key growth factors, such as advancements in automated testing technologies, the shift towards personalized medicine, and expanding healthcare infrastructure in emerging economies, which contribute significantly to the demand surge. Potential opportunities exist in enhancing diagnostic accuracy, integrating artificial intelligence for better data interpretation, and developing portable testing equipment for home use. However, challenges such as regulatory hurdles, high costs associated with advanced diagnostic tools, and a lack of awareness in certain regions could hinder market growth. Price sensitivity and reimbursement issues further complicate market dynamics. As the industry aims to cross these hurdles, areas ripe for innovation include the development of next-generation biomarker panels, improvement in machine learning algorithms for better diagnostic predictions, and the integration of telehealth platforms with CMP testing to enhance accessibility and patient engagement. Efforts towards reducing costs and promoting awareness could yield favorable outcomes, with partnerships between private and public sectors fostering market expansion. The underlying nature of the CMP testing market is robust yet evolving, primarily driven by technological integration and a strong emphasis on health and well-being awareness, presenting a compelling case for stakeholders to invest in future-forward diagnostics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Comprehensive Metabolic Panel Testing Market

The Comprehensive Metabolic Panel Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidence of chronic diseases
  • Potential need for early diagnosis and treatment among the population
  • Rising elderly population coupled with increase in biopsy processes
• Market Restraints
  • Probability of false results on testing
• Market Opportunities
  • Emerging introduction of innovative solutions to improve efficiency and reduce errors
  • Ongoing integration of automated systems in laboratories with bioinformatics and data management solutions
• Market Challenges
  • Changing regulatory system creating ambiguity among manufacturers

Porter's Five Forces: A Strategic Tool for Navigating the Comprehensive Metabolic Panel Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Comprehensive Metabolic Panel Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Comprehensive Metabolic Panel Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Comprehensive Metabolic Panel Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Comprehensive Metabolic Panel Testing Market

A detailed market share analysis in the Comprehensive Metabolic Panel Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Comprehensive Metabolic Panel Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Comprehensive Metabolic Panel Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Comprehensive Metabolic Panel Testing Market

A strategic analysis of the Comprehensive Metabolic Panel Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Comprehensive Metabolic Panel Testing Market, highlighting leading vendors and their innovative profiles. These include Abaxis by Zoetis Inc., Abbott Laboratories, ARUP Laboratories, Baptist Health Medical Group, CENTOGENE N.V., Cleveland HeartLab, Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Inc., Private MD Labs, Quest Diagnostics Incorporated, Scion Lab Services, LLC, Siemens Healthcare GmbH, SYNLAB International GmbH, Testing.com by OneCare Media, and Walk-In Lab, LLC.

Market Segmentation & Coverage

This research report categorizes the Comprehensive Metabolic Panel Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Disease, market is studied across Diabetes, Kidney Disease, and Liver Disease.
• Based on Test Type, market is studied across Electrolytes, Glucose, Kidney Tests, Liver Functional Tests, and Proteins.
• Based on End-User, market is studied across Laboratory and PoC.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of chronic diseases
    • 5.1.1.2. Potential need for early diagnosis and treatment among the population
    • 5.1.1.3. Rising elderly population coupled with increase in biopsy processes
  • 5.1.2. Restraints
    • 5.1.2.1. Probability of false results on testing
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging introduction of innovative solutions to improve efficiency and reduce errors
    • 5.1.3.2. Ongoing integration of automated systems in laboratories with bioinformatics and data management solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Changing regulatory system creating ambiguity among manufacturers
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Comprehensive Metabolic Panel Testing Market, by Disease

• 6.1. Introduction
• 6.2. Diabetes
• 6.3. Kidney Disease
• 6.4. Liver Disease

7. Comprehensive Metabolic Panel Testing Market, by Test Type

• 7.1. Introduction
• 7.2. Electrolytes
• 7.3. Glucose
• 7.4. Kidney Tests
• 7.5. Liver Functional Tests
• 7.6. Proteins

8. Comprehensive Metabolic Panel Testing Market, by End-User

• 8.1. Introduction
• 8.2. Laboratory
• 8.3. PoC

9. Americas Comprehensive Metabolic Panel Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Comprehensive Metabolic Panel Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Comprehensive Metabolic Panel Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abaxis by Zoetis Inc.
• 2. Abbott Laboratories
• 3. ARUP Laboratories
• 4. Baptist Health Medical Group
• 5. CENTOGENE N.V.
• 6. Cleveland HeartLab, Inc.
• 7. Laboratory Corporation of America Holdings
• 8. NeoGenomics Laboratories, Inc.
• 9. Private MD Labs
• 10. Quest Diagnostics Incorporated
• 11. Scion Lab Services, LLC
• 12. Siemens Healthcare GmbH
• 13. SYNLAB International GmbH
• 14. Testing.com by OneCare Media
• 15. Walk-In Lab, LLC